fda shortage semaglutide Injections and the FDA Announces Semaglutide Shortage Resolved

Retatrutide is an investigational triple receptor agonist currently being evaluated in clinical research for its interaction with: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors Its triple-receptor mechanism has made it an active area of investigation in metabolic physiology and endocrine signalling research

If supplementation is advised, oral cyanocobalamin at doses of 50150 micrograms daily is typically used for diet-related deficiency prevention, while intramuscular hydroxocobalamin is the standard treatment in the UK for pernicious anaemia or malabsorption conditions

Allergy concerns occasionally arise, particularly regarding peptide medications

Also in 2025, ice cream manufacturer Two Spoons released an ice cream range that packs 30g of protein per pint and no added sugar